Oxygenta Pharmaceutical Limited share price
BSE: OXYGENTAPH
Key numbers
- Market cap
- ₹ 183 Cr
- Current price
- ₹ 49.61
- 52-week high / low
- ₹ 73 / 43
- Stock P/E
- -
- Book value
- ₹ -11.6
- Dividend yield
- 0.00%
- ROCE
- -33.8%
- ROE
- 51.4%
- Debt to equity
- -2.57
- Sales growth (3 yrs)
- 53.9%
- Profit growth (3 yrs)
- -
- 1-year return
- -29.6%
About Oxygenta Pharmaceutical Limited
Oxygenta Pharmaceutical Limited manufactures and sells pharmaceutical, medical, and veterinary preparations in India and internationally. It offers active pharmaceuticals ingredients, commercial intermediates, and organic fine chemicals, as well as formulations. The company was formerly known as S.S. Organics Limited and changed its name to Oxygenta Pharmaceutical Limited in February 2022. Oxygenta Pharmaceutical Limited was incorporated in 1990 and is based in Hyderabad, India. Oxygenta Pharmaceutical Limited operates as a subsidiary of Virupaksha Organics Limited.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 15 | 14 | 34 | 50 | 37 |
| Operating profit | -7 | -5 | -4 | 0 | 1 |
| Net profit | -6 | -5 | -5 | -2 | -2 |
| EPS (₹) | -1.65 | -1.33 | -1.32 | -0.45 | -0.57 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.